129 related articles for article (PubMed ID: 23934261)
1. Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.
Podolski-Renić A; Jadranin M; Stanković T; Banković J; Stojković S; Chiourea M; Aljančić I; Vajs V; Tešević V; Ruždijić S; Gagos S; Tanić N; Pešić M
Cancer Chemother Pharmacol; 2013 Sep; 72(3):683-97. PubMed ID: 23934261
[TBL] [Abstract][Full Text] [Related]
2. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
Podolski-Renić A; Andelković T; Banković J; Tanić N; Ruždijić S; Pešić M
Biomed Pharmacother; 2011 Aug; 65(5):345-53. PubMed ID: 21775090
[TBL] [Abstract][Full Text] [Related]
3. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation.
Banković J; Andrä J; Todorović N; Podolski-Renić A; Milošević Z; Miljković D; Krause J; Ruždijić S; Tanić N; Pešić M
Exp Cell Res; 2013 Apr; 319(7):1013-27. PubMed ID: 23298945
[TBL] [Abstract][Full Text] [Related]
4. New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides.
Pešić M; Banković J; Aljančić IS; Todorović NM; Jadranin M; Vajs VE; Tešević VV; Vučković I; Momčilović M; Marković ID; Tanić N; Ruždijić S
Food Chem Toxicol; 2011 Dec; 49(12):3165-73. PubMed ID: 21996302
[TBL] [Abstract][Full Text] [Related]
5. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
[TBL] [Abstract][Full Text] [Related]
6. Jatrophane diterpenoids from the latex of Euphorbia dendroides and their anti-P-glycoprotein activity in human multi-drug resistant cancer cell lines.
Jadranin M; Pešić M; Aljančić IS; Milosavljević SM; Todorović NM; Podolski-Renić A; Banković J; Tanić N; Marković I; Vajs VE; Tešević VV
Phytochemistry; 2013 Feb; 86():208-17. PubMed ID: 23079764
[TBL] [Abstract][Full Text] [Related]
7. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
8. Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel.
Podolski-Renić A; Bősze S; Dinić J; Kocsis L; Hudecz F; Csámpai A; Pešić M
Metallomics; 2017 Aug; 9(8):1132-1141. PubMed ID: 28737782
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance related genes and p53 expression in human non small cell lung cancer.
Galimberti S; Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bevilacqua G; Petrini M
Anticancer Res; 1998; 18(4C):2973-6. PubMed ID: 9713494
[TBL] [Abstract][Full Text] [Related]
10. The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells.
Kong D; Ma S; Liang B; Yi H; Zhao Y; Xin R; Cui L; Jia L; Liu X; Liu X
Biomed Pharmacother; 2012 Jun; 66(4):271-8. PubMed ID: 22564245
[TBL] [Abstract][Full Text] [Related]
11. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.
Aldonza MB; Hong JY; Bae SY; Song J; Kim WK; Oh J; Shin Y; Lee SH; Lee SK
PLoS One; 2015; 10(6):e0127841. PubMed ID: 26098947
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
13. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
[TBL] [Abstract][Full Text] [Related]
14. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
Yu ST; Chen TM; Tseng SY; Chen YH
Biochem Biophys Res Commun; 2007 Jun; 358(1):79-84. PubMed ID: 17482571
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation.
Foroutan B; Zitzelsberger H; Bauer V; Ruf AA; Baumgartner A; Anderson D
Arch Iran Med; 2011 Sep; 14(5):321-6. PubMed ID: 21888455
[TBL] [Abstract][Full Text] [Related]
16. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
17. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line.
Lin X; Zhang X; Wang Q; Li J; Zhang P; Zhao M; Li X
Neoplasma; 2012; 59(3):248-56. PubMed ID: 22329846
[TBL] [Abstract][Full Text] [Related]
18. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
Jin J; Wang FP; Wei H; Liu G
Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
[TBL] [Abstract][Full Text] [Related]
20. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
